Pharmaceutical giant AbbVie has lifted its annual earnings outlook after exceeding first-quarter revenue expectations. The company's shares reacted positively in premarket trading as investors weighed the growth trajectory.
- Q1 revenue exceeded analyst expectations
- Full-year earnings outlook revised upward